Technical Analysis for MLYS - Mineralys Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | N/A | N/A | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Wide Bands | Range Expansion | 0.00% | |
Wide Bands | Range Expansion | 0.06% | |
Wide Bands | Range Expansion | 5.45% | |
1,2,3 Retracement Bearish | Bearish Swing Setup | 5.31% | |
Outside Day | Range Expansion | 5.31% | |
Wide Bands | Range Expansion | 5.31% | |
Wide Bands | Range Expansion | -1.94% | |
Inside Day | Range Contraction | 3.50% | |
Wide Bands | Range Expansion | 3.50% | |
Oversold Stochastic | Weakness | 3.50% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
10 DMA Support | 1 day ago |
Down 3% | 1 day ago |
Down 2 % | 1 day ago |
Down 1% | 1 day ago |
Rose Above 10 DMA | 2 days ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/15/2023
Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of patients with uncontrolled or resistant hypertension. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Hypertension Cardiovascular Disease Treatment Of Hypertension Aldosterone Synthase
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Hypertension Cardiovascular Disease Treatment Of Hypertension Aldosterone Synthase
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 21.98 |
52 Week Low | 13.545 |
Average Volume | 262,372 |
200-Day Moving Average | 0.00 |
50-Day Moving Average | 0.00 |
20-Day Moving Average | 15.97 |
10-Day Moving Average | 15.12 |
Average True Range | 1.18 |
RSI | 45.05 |
ADX | 30.48 |
+DI | 13.61 |
-DI | 21.16 |
Chandelier Exit (Long, 3 ATRs) | 16.56 |
Chandelier Exit (Short, 3 ATRs) | 17.08 |
Upper Bollinger Bands | 18.37 |
Lower Bollinger Band | 13.57 |
Percent B (%b) | 0.44 |
BandWidth | 30.08 |
MACD Line | -0.74 |
MACD Signal Line | -0.83 |
MACD Histogram | 0.0857 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 16.76 | ||||
Resistance 3 (R3) | 16.70 | 16.26 | 16.58 | ||
Resistance 2 (R2) | 16.26 | 15.98 | 16.30 | 16.52 | |
Resistance 1 (R1) | 15.96 | 15.81 | 16.11 | 16.03 | 16.46 |
Pivot Point | 15.53 | 15.53 | 15.60 | 15.56 | 15.53 |
Support 1 (S1) | 15.23 | 15.25 | 15.38 | 15.29 | 14.86 |
Support 2 (S2) | 14.79 | 15.07 | 14.83 | 14.80 | |
Support 3 (S3) | 14.49 | 14.79 | 14.74 | ||
Support 4 (S4) | 14.56 |